$757.1M in CY2024 Part D spend240K claims · 53K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Teriparatide used for?
indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) ....
Is there a generic for Teriparatide?
Yes. 3 ANDAs filed at FDA, 3 generic manufacturers currently shipping.
How much does my plan pay for Teriparatide?
Across 329 Part D plans, Teriparatide averages $872.16/unit (NADAC). Lowest available: $595.54/unit. Highest in distribution: $1840.34/unit.
Is Teriparatide on the FDA shortage list?
No. Teriparatide is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (6 approvals on file) · NADAC unit costs: CMS NADAC weekly file (9 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.